Center for Technology Transfer and Commercialization Archives
Jun. 8, 2017—Last week, Vanderbilt’s Department of Radiology and Radiological Sciences hosted the inaugural RadX Innovation Challenge Pitch Event.
Oct. 22, 2015—A wireless electrocardiogram (ECG) system invented at Vanderbilt University and marketed by a Nashville company, InvisionHeart, has received U.S. Food and Drug Administration (FDA) approval.
Oct. 1, 2015—La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.
Apr. 16, 2015—A strategy for commercializing a potential new test for colon cancer that can make tumor cells “glow” won top honors at last week’s TechVenture Challenge.
Mar. 20, 2014—Vanderbilt University Medical Center has launched an automated system for processing and managing Material Transfer Agreements (MTAs), which govern the transfer of biological materials, chemicals, human tissue samples and other materials between institutions to facilitate academic research.
Sep. 26, 2013—Over the past three years, Vanderbilt University more than quadrupled earnings from its technology commercialization efforts — to more than $24.5 million in the 2013 fiscal year that ended June 30, officials have announced.
Mar. 28, 2013—Last month, Vanderbilt University announced a collaboration agreement with GlaxoSmithKline, a leading pharmaceutical and consumer health care company, to develop potential new drugs for severe obesity.
Apr. 28, 2011—Alan Bentley, director of Commercialization for Cleveland Clinic Innovations with the Cleveland Clinic Foundation, has been named assistant vice chancellor of Technology Transfer and Intellectual Property Development.